宫颈癌术前新辅助化疗疗效观察  

Clinical observations of 55 patients with cervical cancer treated with neoadjuvant chemotherapy

作　　者：罗秋育 

机构地区：[1]广东省潮州市潮州医院肿瘤科,521000

出　　处：《中国实用医药》2012年第16期131-132,共2页China Practical Medicine

摘　　要：目的探讨术前新辅助化疗对Ⅰb～Ⅱb期宫颈癌高危患者的近期疗效。方法 55例宫颈癌术前采用1～3个疗程的静脉化疗后手术,观察近期疗效。结果临床近期有效率达67.3%,手术切除率达100%。结论术前新辅助化疗对Ⅰb～Ⅱb期宫颈癌高危患者有效,能明显缩小局部肿瘤,提高手术切除率,可以提高治疗效果和进一步改善生活质量。Objective To investigate the short-term effect of neoadjuvant chemotherapy before opera- tion on high-risk patients of cervical cancer in the I b and Ⅱ b periods. Methods 55 patients with cervical cancer were treated with 1-3 courses of intravenous chemotherapy before operation and the short-term efficacy was evaluated. Results The short-term clinical effective rate was 67. 3% and the surgical resection rate reached as high as 100%. Conclusion The neoadjuvant chemotherapy before operation was effective on high- risk patients of cervical cancer in the I b and 1I b periods. After the treatment, tumor local was reduced signifi- cantly and the resection rate was increased. An improved life quality could be realized thereupon by an improved therapeutic effect.

关 键 词：宫颈癌 新辅助化疗 顺铂 手术治疗 

分 类 号：R737.33[医药卫生—肿瘤]